167 related articles for article (PubMed ID: 1678663)
1. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.
Glazer WM; Morgenstern H; Doucette JT
Br J Psychiatry; 1991 Jun; 158():822-8. PubMed ID: 1678663
[TBL] [Abstract][Full Text] [Related]
2. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
[TBL] [Abstract][Full Text] [Related]
3. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
Liddle PF; Barnes TR; Speller J; Kibel D
Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
[TBL] [Abstract][Full Text] [Related]
4. Predictors of the course of tardive dyskinesia in patients receiving neuroleptics.
Bergen J; Kitchin R; Berry G
Biol Psychiatry; 1992 Oct; 32(7):580-94. PubMed ID: 1360260
[TBL] [Abstract][Full Text] [Related]
5. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
Chiu H; Lau J; Lam L; Shum P
Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
[TBL] [Abstract][Full Text] [Related]
6. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
Brown KW; White T
Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
[TBL] [Abstract][Full Text] [Related]
7. A 10-year follow-up study of tardive dyskinesia.
Yassa R; Nair NP
Acta Psychiatr Scand; 1992 Oct; 86(4):262-6. PubMed ID: 1360742
[TBL] [Abstract][Full Text] [Related]
8. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
Barnes TR; Liddle PF; Curson DA; Patel M
Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
[No Abstract] [Full Text] [Related]
9. [Schizophrenic deficit syndrome and neurologic tolerance].
Verdoux H; Bourgeois M
Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia and positive symptoms of schizophrenia.
White T; Brown KW; Woods JP
Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
Cohen S; Khan A; Zheng Y; Chiles J
Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
[TBL] [Abstract][Full Text] [Related]
12. The lifetime outcome and involuntary movements of schizophrenia never treated with neuroleptic drugs. Four rare cases in Ireland.
Waddington JL; Youssef HA
Br J Psychiatry; 1990 Jan; 156():106-8. PubMed ID: 1967543
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
Yuen O; Caligiuri MP; Williams R; Dickson RA
Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
[TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
Waddington JL; Youssef HA; Kinsella A
Psychol Med; 1990 Nov; 20(4):835-42. PubMed ID: 1980953
[TBL] [Abstract][Full Text] [Related]
15. Comment on "tardive dyskinesia circa 2006".
Rosenheck RA
Am J Psychiatry; 2007 Jan; 164(1):170; author reply 170. PubMed ID: 17202564
[No Abstract] [Full Text] [Related]
16. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.
Cavallaro R; Regazzetti MG; Mundo E; Brancato V; Smeraldi E
Neuropsychopharmacology; 1993 May; 8(3):233-9. PubMed ID: 8099483
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia in 2 patients treated with ziprasidone.
Ananth J; Burgoyne KS; Niz D; Smith M
J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings.
Gold JM; Egan MF; Kirch DG; Goldberg TE; Daniel DG; Bigelow LB; Wyatt RJ
Biol Psychiatry; 1991 Sep; 30(6):587-99. PubMed ID: 1681948
[TBL] [Abstract][Full Text] [Related]
19. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
Brown KW; White T
Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
[TBL] [Abstract][Full Text] [Related]
20. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
